Development of novel targeted therapies in the treatment of malignant glioma.
Publication
, Journal Article
Rich, JN; Bigner, DD
Published in: Nat Rev Drug Discov
May 2004
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Nat Rev Drug Discov
DOI
ISSN
1474-1776
Publication Date
May 2004
Volume
3
Issue
5
Start / End Page
430 / 446
Location
England
Related Subject Headings
- Tumor Suppressor Protein p53
- Receptors, Vascular Endothelial Growth Factor
- Pharmacology & Pharmacy
- Molecular Biology
- Middle Aged
- Humans
- Glioma
- Epidermal Growth Factor
- Clinical Trials as Topic
- Cell Cycle
Citation
APA
Chicago
ICMJE
MLA
NLM
Rich, J. N., & Bigner, D. D. (2004). Development of novel targeted therapies in the treatment of malignant glioma. Nat Rev Drug Discov, 3(5), 430–446. https://doi.org/10.1038/nrd1380
Rich, Jeremy N., and Darell D. Bigner. “Development of novel targeted therapies in the treatment of malignant glioma.” Nat Rev Drug Discov 3, no. 5 (May 2004): 430–46. https://doi.org/10.1038/nrd1380.
Rich JN, Bigner DD. Development of novel targeted therapies in the treatment of malignant glioma. Nat Rev Drug Discov. 2004 May;3(5):430–46.
Rich, Jeremy N., and Darell D. Bigner. “Development of novel targeted therapies in the treatment of malignant glioma.” Nat Rev Drug Discov, vol. 3, no. 5, May 2004, pp. 430–46. Pubmed, doi:10.1038/nrd1380.
Rich JN, Bigner DD. Development of novel targeted therapies in the treatment of malignant glioma. Nat Rev Drug Discov. 2004 May;3(5):430–446.
Published In
Nat Rev Drug Discov
DOI
ISSN
1474-1776
Publication Date
May 2004
Volume
3
Issue
5
Start / End Page
430 / 446
Location
England
Related Subject Headings
- Tumor Suppressor Protein p53
- Receptors, Vascular Endothelial Growth Factor
- Pharmacology & Pharmacy
- Molecular Biology
- Middle Aged
- Humans
- Glioma
- Epidermal Growth Factor
- Clinical Trials as Topic
- Cell Cycle